114 related articles for article (PubMed ID: 36479909)
1. KMT2A-D pathogenicity, prevalence, and variation according to a population database.
Larson JK; Hunter-Schlichting DN; Crowgey EL; Mills LJ; Druley TE; Marcotte EL
Cancer Med; 2023 Mar; 12(6):7234-7245. PubMed ID: 36479909
[TBL] [Abstract][Full Text] [Related]
2. Frequency of pathogenic/likely pathogenic germline variants in cancer-related genes among children with acute leukemia in Saudi Arabia.
Alsultan A; Essa M; Aljefri A; Ayas M; Alharbi M; Alkhayat N; Al-Anzi F; Yassin F; Alkasim F; Alharbi Q; Abdullah S; Jastaniah W
Pediatr Blood Cancer; 2020 Jul; 67(7):e28340. PubMed ID: 32359129
[TBL] [Abstract][Full Text] [Related]
3. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Yang F; Long N; Anekpuritanang T; Bottomly D; Savage JC; Lee T; Solis-Ruiz J; Borate U; Wilmot B; Tognon C; Bock AM; Pollyea DA; Radhakrishnan S; Radhakrishnan S; Patel P; Collins RH; Tantravahi S; Deininger MW; Fan G; Druker B; Shinde U; Tyner JW; Press RD; McWeeney S; Agarwal A
Blood; 2022 Feb; 139(8):1208-1221. PubMed ID: 34482403
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
[TBL] [Abstract][Full Text] [Related]
5. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
6. Three de novo variants in KMT2A (MLL) identified by whole exome sequencing in patients with Wiedemann-Steiner syndrome.
Luo S; Bi B; Zhang W; Zhou R; Chen W; Zhao P; Huang Y; Yuan L; He X
Mol Genet Genomic Med; 2021 Oct; 9(10):e1798. PubMed ID: 34469078
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Kim J; Luo W; Wang M; Wegman-Ostrosky T; Frone MN; Johnston JJ; Nickerson ML; Rotunno M; Li SA; Achatz MI; Brodie SA; Dean M; de Andrade KC; Fortes FP; Gianferante M; Khincha P; McMaster ML; McReynolds LJ; Pemov A; Pinheiro M; Santiago KM; Alter BP; Caporaso NE; Gadalla SM; Goldin LR; Greene MH; Loud J; Yang XR; Freedman ND; Gapstur SM; Gaudet MM; Calista D; Ghiorzo P; Fargnoli MC; Nagore E; Peris K; Puig S; Landi MT; Hicks B; Zhu B; Liu J; Sampson JN; Chanock SJ; Mirabello LJ; Morton LM; Biesecker LG; Tucker MA; Savage SA; Goldstein AM; Stewart DR
Genome Med; 2018 Dec; 10(1):99. PubMed ID: 30583724
[TBL] [Abstract][Full Text] [Related]
8. Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.
Ikeda J; Shiba N; Tsujimoto SI; Yoshida M; Nakabayashi K; Ogata-Kawata H; Okamura K; Takeuchi M; Osumi T; Tomizawa D; Hata K; Kiyokawa N; Ito S; Kato M
Genes Chromosomes Cancer; 2019 Sep; 58(9):669-672. PubMed ID: 30869817
[TBL] [Abstract][Full Text] [Related]
9. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
[TBL] [Abstract][Full Text] [Related]
10. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
[TBL] [Abstract][Full Text] [Related]
12. [Identification of a novel frameshift variant in the KMT2A gene of a child with Wiedemann-Steiner syndrome].
Wu R; Tang W; Qiu K; Zhang X; Meng Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jun; 39(6):630-633. PubMed ID: 35773769
[TBL] [Abstract][Full Text] [Related]
13. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric
Pollard JA; Guest E; Alonzo TA; Gerbing RB; Loken MR; Brodersen LE; Kolb EA; Aplenc R; Meshinchi S; Raimondi SC; Hirsch B; Gamis AS
J Clin Oncol; 2021 Oct; 39(28):3149-3160. PubMed ID: 34048275
[TBL] [Abstract][Full Text] [Related]
14. Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms.
Yin L; Xie S; Chen Y; Li W; Jiang X; Li H; Li J; Wu Z; Xiao X; Zhang G; Cheng Z; Peng H
Ann Hematol; 2021 Sep; 100(9):2229-2240. PubMed ID: 34228147
[TBL] [Abstract][Full Text] [Related]
15. A new variant of KMT2A(MLL)-FLNA fusion transcript in acute myeloid leukemia with ins(X;11)(q28;q23q23).
Matveeva E; Kazakova A; Olshanskaya Y; Tsaur G; Shelikhova L; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A
Cancer Genet; 2015 Apr; 208(4):148-51. PubMed ID: 25892123
[TBL] [Abstract][Full Text] [Related]
16. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
17. Expanding ACMG variant classification guidelines into a general framework.
Masson E; Zou WB; Génin E; Cooper DN; Le Gac G; Fichou Y; Pu N; Rebours V; Férec C; Liao Z; Chen JM
Hum Genomics; 2022 Aug; 16(1):31. PubMed ID: 35974416
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
[TBL] [Abstract][Full Text] [Related]
19. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
20. Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report.
Valentine MC; Linabery AM; Chasnoff S; Hughes AE; Mallaney C; Sanchez N; Giacalone J; Heerema NA; Hilden JM; Spector LG; Ross JA; Druley TE
Leukemia; 2014 Jun; 28(6):1235-41. PubMed ID: 24301523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
